Study design and participants
Alzheimer, memory complaint, MAPT
ALZHEIMER
All subjects included in the present analysis were participants, from the MAPT and MAPT-PLUS studies, that were tested for amyloid blood biomarkers (Fig. Place of the amyloid plasma analysis in relation to MAPT and ancillary studies. MAPT multidomain Alzheimer’s preventive trialBased on MAPT inclusion criteria, subjects included in the present analysis were non-demented, 70 years old and over, and fulfilled one of the following three criteria: spontaneous memory complaint, limitation in one instrumental activity of daily living, or slow gait speed [